Vascular endothelial growth factor (VEGF) is a multifunctional cytokine tha
t plays a prominent role in normal vascular biology and pathology. In an ex
perimental wound model, the mechanical disruption of monolayers of cultured
endothelial cells resulted in two phenotypically distinct cell subpopulati
ons in which VEGF was internalized by alternative endocytotic pathways and
delivered to different subcellular compartments. In the cells away from the
wound, VEGF was internalized via the classical receptor-mediated endocytos
is pathway and accumulated in the endosomal compartment, whereas in the cel
ls situated at the edges of a wound, VEGF was rapidly taken up and transloc
ated to the nucleus, VEGF internalization and subsequent nuclear accumulati
on only occurred for a short period of time after the wounding and was spec
ifically abolished by antibodies that bind to the KDR binding site of VEGF.
In the cells with VEGF nuclear accumulation, the levels of wound healing re
lated proteins, such as Factor VIII (FVIII), tissue factor (TF) and tissue
plasminogen activator, rapidly and dramatically increased compared to the c
ells that internalized VEGF via the classical endocytotic pathway. The incr
ease in FVIII and TF was abolished when the nuclear transport is blocked. T
hese data suggest that nuclear VEGF accumulation may be involved in modulat
ing the levels of the proteins of the coagulation and fibrinolysis pathways
.